Health & Science

The advisers to the Food and Drug Administration voted Thursday to recommend a lower-dose booster shot for seniors and other high-risk groups.

Some of the top women in Delaware’s growing life sciences industry offered advice for students and others looking to work in STEM fields in an online symposium.

We're joined by Daniel Lieberman, author of Exercised: Why Something We Never Evolved to Do Is Healthy and Rewarding

Putting off surgeries or routine treatments for serious illnesses has become common during the pandemic, a new NPR/Harvard poll finds.

Hollywood’s Captain Kirk, 90-year-old William Shatner, has blasted into space and safely returned to Earth in a convergence of science fiction and science reality.

New Jersey will use federal stimulus dollars to offer $1,000 bonuses to help child care providers recruit new workers and retain existing staff.

Even amid the coronavirus pandemic, heart disease continues to be the nation's leading cause of death. And much of it is preventable through a healthier diet.

Philadelphia’s health commissioner said the city risks another epidemic of preventable deaths if health care workers don’t get inoculated against the coronavirus.

Delco’s health department could be created this month, but it won’t have any power until the Pennsylvania Department of Health gives the final stamp of approval.

As William Shatner prepares to be beamed up at age 90 for his first real-life spaceflight, he’s bringing out the awe in people around a rural Texas spaceport.

The Gulf of Maine is among the fastest-warming large water bodies on the planet, making the puffins' fate a test-case for how climate change could disrupt marine ecosystems.

After the FDA advisers give their recommendation, the agency itself will make an official decision on whether to authorize boosters.

The NJ gubernatorial race, nursing shortages and Sonia Manzano, who played the role of Maria on Sesame Street, on the new PBS show "Alma's Way, inspired by her life.

The FDA will scrutinize company data on the safety and effectiveness of the drug, molnupiravir, before rendering a decision.

In early tests, the drug reduced the chance of people being hospitalized for or dying from COVID-19 by 50%. What about safety?